Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Cbre Global Real Estate Income Fund | IGR | Sep 19, 2024 | 6.47 | -0.99 |
CBRE Group | CBRE | Sep 19, 2024 | 122.49 | +1.78 |
CCC Intelligent Solutions | CCCS | Sep 19, 2024 | 11.02 | +1.85 |
Ccsc Technology International | CCTG | Sep 19, 2024 | 1.84 | +5.74 |
CDT Environmental Technology Investment Holdings | CDTG | Sep 19, 2024 | 3.62 | -0.28 |
CDW | CDW | Sep 19, 2024 | 227.87 | +2.82 |
CEA Industries | CEAD | Sep 19, 2024 | 7.00 | +2.04 |
CECO Environmental | CECO | Sep 19, 2024 | 29.00 | +3.65 |
Cedar Realty Trust B Pref | CDR-B | Sep 19, 2024 | 14.77 | +1.74 |
Cedar Realty Trust C Pref | CDR-C | Sep 19, 2024 | 13.25 | +0.68 |
CEF Income Composite Powershares | PCEF | Sep 19, 2024 | 19.64 | +0.72 |
Cel-Sci | CVM | Sep 19, 2024 | 1.10 | -1.79 |
Celanese | CE | Sep 19, 2024 | 130.09 | +2.94 |
Celcuity | CELC | Sep 19, 2024 | 15.19 | +1.20 |
Celestica | CLS | Sep 19, 2024 | 49.71 | +6.15 |
Celldex Therapeutics | CLDX | Sep 19, 2024 | 41.16 | -1.65 |
Cellebrite | CLBT | Sep 19, 2024 | 17.44 | +1.10 |
Cellectar Biosciences | CLRB | Sep 19, 2024 | 2.11 | +0.48 |
Cellectis ADR | CLLS | Sep 19, 2024 | 2.32 | +1.75 |
Celsius | CELH | Sep 19, 2024 | 34.07 | -0.61 |
Celularity A | CELU | Sep 19, 2024 | 2.76 | +7.81 |
Cementos Pacasmayo ADR | CPAC | Sep 19, 2024 | 5.68 | -0.53 |
CEMEX ADR | CX | Sep 19, 2024 | 6.36 | +2.91 |
Cemtrex | CETX | Sep 19, 2024 | 0.15 | +3.38 |
Cencora | COR | Sep 19, 2024 | 226.56 | -0.84 |
Cenntro | CENN | Sep 19, 2024 | 1.18 | +0.85 |
Cenovus Energy | CVE | Sep 19, 2024 | 17.22 | +3.61 |
Centene | CNC | Sep 19, 2024 | 75.63 | -0.90 |
CenterPoint Energy | CNP | Sep 19, 2024 | 28.26 | +0.18 |
Centerra Gold | CGAU | Sep 19, 2024 | 6.90 | +1.92 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.